跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
赫赛莱 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Trastuzumab Emtansine for Injection
Approved
生物制品
Trastuzumab Emtansine for Injection
Roche Pharma (Schweiz) AG
🇨🇳 National Medical Products Administration
Approval Date
Jan 21, 2020
Approval ID
7ucitqheFSB
Company
Roche Pharma (Schweiz) AG
Type
生物制品
Approval Details
Approval Id
7ucitqheFSB
Approval Number
S20200002
Generic Name
注射用恩美曲妥珠单抗
Generic Name En
Trastuzumab Emtansine for Injection
Trade Name
赫赛莱
Drug Type
生物制品
Dosage Form
注射剂
Strength
160mg/瓶
Reg Date
2020-01-21
Expired Date
2025-01-20
Company Name
Roche Pharma (Schweiz) AG
Company Address
Grenzacherstrasse 124, 4058 Basel, Switzerland
Production Company Name
F. Hoffmann-La Roche Ltd
Production Company Address
Wurmisweg CH-4303 Kaiseraugst Switzerland
Company Detail Path
/organization/roche-pharma-schweiz-ag
Production Company Detail Path
/organization/f-hoffmann-la-roche-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 21, 2020
Approval ID
7ucitqheFSB
Type
生物制品
Back to NMPA Approvals